Spreadsheet: 4c67a92e-6e82-4a30-a0a4-3ac8962f5555
Sheet: Sheet1

Unnamed: 0 | Unnamed: 1 | Unnamed: 2
 | ISS evaluation: follow up on recommendations
Executive Summary Reference | Recommendations | GAVI Secretariat Management Response
1 | Continue to provide ISS funding | Agree
2 | Continue to use DTP3 as indicator | Agree
3 | Continue allowing flexibility in how and when to use funds | Agree, subject to financial reporting in line with Transparency and Accountability policy
4 | Reconsider how ISS funding is calculated | The Independent Review Committee will be asked to consider this recommendation
5 | Investigate alternative approaches for working with countries in conflict or recovering from conflict (e.g. post conflict investment) | A Task Team (Fragile states) has been established and is expecting to make suggestions to the board in second quarter 2008
6 | Reconsider amount of reward in high coverage countries - $20 may not provide sufficient incentive | A Task Team  has been established and is expecting to make suggestions to the board in second quarter 2008
7 | Consider additional and/or different measures of immunization performance in higher coverage countries e.g.equity or coverage consistency | A Task Team  (same as above) has been established and is expecting to make suggestions to the board in second quarter 2008
8 | Revise the ISS investment and reward structure balancing GAVI’s internal equity objectives, cost effectiveness of various options, estimated health impact and overall resource limitations | The recommendations of  the different task teams will be revised by the Working Group to ensure consistency with GAVI strategic objectives
9 | Increase advocacy efforts at global and country level | Agree; the Secretariat  will work with Alliance partners to identify and implement invigorated advocacy campaign by second quarter 2008.
10 | Increase efforts to coordinate support from all GAVI partners at country level | The Working Group will review how country-level co-ordination will be improved.
11 | Establish mechanism to support underperforming countries and address allegations of misuse of funds | Cluster officers have been appointed at GAVI secretariat to have a close follow up with partners. Additional support to partners is also discussed during the preparation of the   annual work plan. Also see response to Recommendation 15.
12 | More consistently adjust the projected number of children immunized with DTP3 as the basis for reward calculation | The Independent Review Committee will be asked to consider this recommendation
13 | Require that countries have an established technical subgroup within the ICC. Countries should be required to report on activities of technical team in the annual progress report | A Task Team  (same as above) has been established and is expecting to make suggestions to the board in second quarter 2008
14 | Total immunization funding esp. non-vaccine funding monitored at global level by aggregating country data | Countries provide information on total immunisation funding, including non-vaccine funding in their comprehensive multi year plans. The information is updated in the Annual Progress Reports.  Aggregate country information will be provided through analysis of the country support database on an annual basis
15 | Establish a process to follow up on reported expenditure and coverage information that do not total correctly or are inconsistent with previous years | Cluster officers have been appointed at GAVI secretariat to have a close look at information provided by countries. In addition, GAVI is developing a "Transparency and Accountability" policy that will set overall policy aims on oversight of use of funds and propose a set of implementation guidelines that reflect the differing financial management circumstances in each country. Both the policy and implementation guidelines will be Paris-Declaration compliant and seek to rely on pooled funding mechanisms and national oversight capacity wherever possible. Having received initial guidance from the GAVI Alliance and Fund Executive Committees in September 2007, it is anticipated that the implementation guidelines will be presented by June 2008
16 | Continue to use in-country data collection to monitor performance at country level | Agree. This is done through Annual progress report and WHO/UNICEF Joint Reporting Form
17 | Regular analysis of internal performance based on time elapsed between funding approval and disbursement | Given the several funding sources that GAVI uses, there is an internal process - that is often complex - surrounding the use of these funds. Management agrees with monitoring the intervals between approval and disbursement: the length of time between approval and disbursement is a metric on the GAVI dashboard. This tool will aid in monitoring and identifying causes of delay.